Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Biometrics as a Service in Healthcare Market Worth $1.1 billion | MarketsandMarkets™

Published

on

biometrics-as-a-service-in-healthcare-market-worth-$1.1-billion-|-marketsandmarkets™

CHICAGO, April 4, 2024 /PRNewswire/ — Biometrics as a Service in Healthcare Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 20.7% from 2023 to 2028 according to a new report by MarketsandMarkets™.

The amalgamation of biometric data with cutting-edge analytics and artificial intelligence (AI) has emerged as a transformative force within the healthcare sector, significantly bolstering market growth. This synergistic approach empowers healthcare organizations to extract invaluable insights from the vast reservoir of biometric information at their disposal. These insights pave the way for the realization of personalized medicine, facilitating tailored treatments for patients, precise disease prediction, and optimization of treatment strategies. As the healthcare industry increasingly recognizes the potential of this combination, the demand for biometric solutions that integrate seamlessly with advanced analytics and AI continues to surge, propelling the market forward and enhancing the quality of care delivered to patients. The ethical debates encompassing biometrics, specifically concerns related to obtaining informed consent for data collection and the potential for misuse, have the potential to create regulatory challenges and foster public skepticism, posing significant obstacles to the unhindered growth of the biometrics market within the healthcare sector.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71676592
Browse in-depth TOC on “Biometrics as a Service in Healthcare Market”209 – Tables45 – Figures200 – Pages
Biometrics as a Service in Healthcare Market Scope:
Report Coverage
Details
Market Revenue in 2023
$0.4 billion
Estimated Value by 2028
$1.1 billion
Growth Rate
Poised to grow at a CAGR of 20.7%
Market Size Available for
2021–2028
Forecast Period
2023–2028
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
By Component, By Modality, By Solution Type, By Application, By End User & By Region
Geographies Covered
North America, Europe, Asia Pacific, Latin America and Middle East And Africa
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Increasing demand for advanced biometric solutions designed for authentication and identification applications
Key Market Drivers
Growing focus on Government initiatives supporting the adoption of biometrics in healthcare
“Software segment accounted for the largest share and is expected to grow at the highest rate during the forecast period.”
The ascendancy of software-driven biometric solutions in the market is fundamentally underpinned by their dynamic capacity to harness the continuous stream of technological innovations. These advancements encompass notable enhancements in the precision of facial recognition algorithms and the evolution of touchless authentication methods. Not only do these developments significantly elevate the user-friendliness of biometric systems, but they also furnish an unprecedented level of security. Consequently, the proliferation of software-based biometric solutions is emblematic of an industry poised for continued expansion, where adaptability and technological sophistication are paramount in fulfilling the dual imperatives of enhanced user experience and robust security within the market landscape.
“The multimodal modality segment accounted for the largest share and is expected to grow at the highest rate during the forecast period.”
The strategic adoption of multimodal biometric systems has emerged within the healthcare sector as a cornerstone strategy for fortifying security measures. These multifaceted solutions are instrumental in regulating access to highly secure areas, notably pharmaceutical storage facilities, and critical resource zones. By integrating multimodal biometrics, healthcare organizations effectively safeguard valuable assets while ensuring stringent access control, emblematic of an industry committed to bolstering security infrastructure. This concerted commitment to heightened security, marked by the strategic deployment of multimodal biometric solutions, substantiates the ongoing growth trajectory of the healthcare biometrics market, a testament to the sector’s unwavering dedication to safeguarding its most precious resources and assets.
“Fingerprint solution type segment accounted for the largest share of the global biometrics as a service in the healthcare market.”
Fingerprint biometric solutions have garnered substantial attention in the healthcare sector due to their distinct cost-effectiveness relative to alternative biometric modalities. This cost-efficiency appeals particularly to healthcare organizations seeking to optimize their operational budgets without compromising security standards. By providing a judicious balance between affordability and robust authentication, fingerprint biometrics have emerged as an enticing proposition for healthcare entities, bolstering their adoption and propelling the sustained expansion of the healthcare biometrics market. This underscores the healthcare industry’s commitment to resource optimization while maintaining stringent security protocols.
“Medical record and data center security application segment accounted for the largest share and is expected to grow at the highest rate during the forecast period of the biometrics as a service in the healthcare market.”
In the contemporary landscape of telehealth and remote healthcare services, biometric solutions are pivotal in enabling secure access to critical medical records from diverse geographical locations. This capability, marked by its intrinsic commitment to data security, assuages concerns related to privacy and confidentiality. As healthcare delivery increasingly transcends traditional boundaries, the integration of biometric authentication underscores the industry’s dedication to fortifying data protection measures. This strategic alignment bolsters the expansion of the healthcare biometrics market, signifying its role as an enabler of secure and accessible healthcare services on a global scale.
“Hospitals and clinics end-user segment held the largest market share growing at the highest CAGR during the forecast period of the biometrics as a service in the healthcare market.”
Hospitals and clinics, as custodians of sensitive patient data, operate under the imperative to adhere rigorously to healthcare regulations such as HIPAA (Health Insurance Portability and Accountability Act). The integration of biometric solutions stands as an instrumental strategy in achieving and maintaining regulatory compliance. These solutions, characterized by their fortification of data security and precise patient identification, epitomize the healthcare sector’s unwavering commitment to safeguarding patient information and upholding the tenets of healthcare laws. Consequently, the burgeoning adoption of biometrics underscores its role as a pivotal enabler in augmenting data security and ensuring compliance within the healthcare industry, thus propelling the continued expansion of the healthcare biometrics market.
“North America to witness significant growth during the forecast period.”
In 2022, North America held the largest market share for biometrics as a service in the healthcare market. The demographic shift towards an aging population within the region has catalyzed a surge in healthcare demand, accentuating the importance of streamlined patient identification and meticulous record management. In response to this evolving healthcare landscape, the adoption of advanced biometric solutions has emerged as an imperative. These solutions, underpinned by their capacity to enhance patient identification accuracy and optimize the management of healthcare records, stand as a strategic imperative within the healthcare sector. Consequently, their pervasive integration is emblematic of the industry’s dedication to efficiently meeting the escalating healthcare demands of an aging population, signifying a pivotal driver in the sustained growth trajectory of the healthcare biometrics market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=71676592
Biometrics as a Service in Healthcare Market Dynamics:
Drivers:
Growing focus on Government initiatives supporting the adoption of biometrics in healthcareRestraints:
High costs associated with biometric systemsOpportunities:
Increasing demand for advanced biometric solutions designed for authentication and identification applicationsChallenge:
Complexities in implementing recognition technologies within existing healthcare systemsKey Market Players of Diagnostic Contract Manufacturing Industry:
Some of the prominent players operating in the biometrics as a service in the healthcare market are NEC Corporation (Japan), Fujitsu Limited (Japan), Imprivata, Inc. (US), Suprema Inc. (South Korea), BIO-key International, Inc. (US), Thales (US), ASSA ABLOY (HID Global Corporation) (US), Cognitec Systems GmbH (Germany), Hitachi, Ltd. (Japan), Idex Biometrics ASA (Europe), Spectra Technovision(India) Pvt. Ltd. (India), Aware, Inc. (US), Aratek (US), Advent International, L.P. (US), NICE Ltd. (Israel), Voice Biometrics Group (US), Imageware (US).
Breakdown of supply-side primary interviews:
By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25%By Designation: C-level – 25%, Director-level – 55%, and Others – 20%By Region: North America – 40%, Europe – 25%, APAC – 20%, Latin America – 10%, Middle East & Africa – 5%Recent Developments of Diagnostic Contract Manufacturing Industry:
In June 2023, NEC Corporation (Japan) announced the launch of its new biometric authentication solution, NEC Biometric Engine. The solution is designed to help healthcare organizations improve patient safety and security by providing a more secure and convenient way to identify patients.In May 2023, Fujitsu (Japan) announced the expansion of its biometrics portfolio with the launch of its new palm vein authentication solution. The solution is designed to be used in a variety of healthcare applications, such as patient identification, access control, and payment.In 2022, NEC Corporation (Japan) launched a multimodal biometric authentication solution, facilitating rapid and highly accurate authentication, achieved by requiring individuals to simply direct their face towards the authentication device, while maintaining a remarkably low false acceptance rate of less than one in 10 billion.In 2022, Imprivata (US) acquired OGiTiX Software AG (Germany), a leading provider of agile identity and access management (IAM) solutions for the DACH region. This development strengthened Imprivata’s presence in the DACH market.Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=71676592
Biometrics as a Service in Healthcare Market – Key Benefits of Buying the Report:
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.
This report provides insights into the following pointers:
Analysis of key drivers (growing need for patient identification and authentication, rising incidences of medical identity theft and data breaches, growing initiatives supporting biometrics adoption in healthcare), restraints (high costs associated with biometric systems, increased hygiene concerns and high risk of transmission of infectious diseases posed by touch-based biometric solutions), opportunities (increasing demand for advanced biometric solutions designed for authentication and identification applications, growing focus on availability of Biometric-as-a-Service solutions), and challenges (failure in detecting authorized and unauthorized users, complexities in implementing recognition technologies within existing healthcare systems) influencing the growth of healthcare biometrics/biometrics as a service in healthcare market.Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in biometrics as a service in the healthcare market.Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of biometrics as a service across regions.Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in biometrics as a service in the healthcare market.Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in biometrics as a service in the healthcare market.Related Reports:
Patient Engagement Solutions Market – Global Forecasts to 2028
Remote Patient Monitoring Market – Global Forecasts to 2028
Patient-Derived Xenograft/PDX Model Market – Global Forecasts to 2028
Patient Handling Equipment Market – Global Forecasts to 2027
Patient Positioning Systems Market – Global Forecasts to 2027
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Insights: https://www.marketsandmarkets.com/ResearchInsight/biometrics-as-a-service-in-healthcare-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/biometrics-as-a-service-in-healthcare.asp
Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/biometrics-as-a-service-in-healthcare-market-worth-1-1-billion–marketsandmarkets-302108174.html

Continue Reading

Artificial Intelligence

Clario awarded SAS Global Service Provider Partner of the Year

Published

on

clario-awarded-sas-global-service-provider-partner-of-the-year

This award recognizes Clario’s commitment to delivering the levels of excellence and innovation required to ensure data integrity in clinical trials.
Clario receives award for its broad endpoint technology solutions and scientific expertise, which together enhance data integrity and regulatory compliance for its customers.Clario’s services, combined with SAS® analytics solutions, set a new benchmark in data management, underscoring the value Clario brings to its customers.Coupled with Clario’s support of 62% of last year’s FDA approvals and the two recent data security certifications, these accomplishments emphasize its significant contribution to healthcare research advancements.PHILADELPHIA, April 23, 2024 /PRNewswire/ — Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced it has been awarded the 2024 SAS Global Service Provider Partner of the Year for delivering superior value to its customers. SAS, a leader in data and AI, celebrated the recipients of its annual partner awards at SAS Innovate, its flagship event for business leaders, technical users and SAS Partners. This award recognizes Clario’s commitment to excellence and innovation, which together ensure that the clinical trial data Clario delivers to its customers meets stringent data integrity standards and global regulatory compliance requirements.

Clario has consistently demonstrated its expertise in developing and integrating advanced technological solutions to meet the evolving clinical trial needs of its customers. Clario’s services, combined with SAS technology, standardize clinical data for regulatory compliance purposes. This standardization streamlines the regulatory review process, ensures data integrity, and facilitates compliance with regulatory standards set by entities such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
“We are honored to be recognized as the SAS Global Service Provider Partner of the Year. This award reaffirms our commitment to leading the way in innovative technological solutions for high-quality and more consistent clinical trials for our customers around the world,” said Jay Ferro, Chief Information, Technology and Product Officer at Clario. “Having supported 62% of the FDA approvals last year, along with our recent data security milestones ISO 27001:2022 certification and SOC2 Type II attestation, Clario is powering the advancement of healthcare research, ensuring we meet the highest standards in data management.”
Clario’s broadest endpoint technological solutions and its partnership with SAS address the challenges of data management in healthcare research. This collaboration not only ensures data integrity and streamlines regulatory processes but also underscores the value it brings to its customers.
For more information on Clario and its clinical trial data management platform, please visit Clario.com.
About Clario
Clario is a leading healthcare research and technology company that generates the highest quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence-generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints.
Clario’s science, technology, and operational experts have helped deliver over 26,000 trials and contributed to over 800 regulatory approvals in more than 100 countries. For more than 50 years, we have provided deep scientific expertise and the broadest endpoint technologies to help transform lives around the world.
Clario Media Contact:Alexis NavratilCommunications [email protected]
Logo – https://mma.prnewswire.com/media/1677749/Clario_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clario-awarded-sas-global-service-provider-partner-of-the-year-302123703.html

Continue Reading

Artificial Intelligence

Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets

Published

on

clarivate-acquires-global-qms,-inc.,-expanding-life-sciences-&-healthcare-segment-into-new-markets

Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management
LONDON, April 23, 2024 /PRNewswire/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced that it has acquired Global QMS, Inc., known as Global Q, a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. Financial terms of the transaction were not disclosed. 

Global Q supports leading pharma, medtech and biotech companies by providing comprehensive access to linked and standardized workflow-ready data via its SaaS platform, Optiqs360 Digital™. The platform includes MediGPT – WorkCenter™ and MediGPT – IntelliWriter™, solutions that provide clients with interconnected data visibility and common user interfaces, across internal and external sources of record. The tools support the complex workflows and reporting needs of clinical, regulatory, product lifecycle and quality management professionals, significantly streamlining annual product reviews, medical device reports and supply chain insights. 
Clarivate brings together connected data, deep expertise and intelligence solutions to empower life sciences and healthcare companies to deliver safe, effective and commercially successful treatments to patients faster. The acquisition of Global Q bolsters a robust integrated platform of life science intelligence solutions from pre-clinical and clinical offerings and further expands Clarivate capabilities in manufacturing and supply chain management to include regulatory report authoring and compliance management. The workflow and reporting capabilities of Global Q complement the Clarivate Cortellis Generics Intelligence solution for Active Pharmaceutical Ingredient (API) tracking. The addition of these cloud-based solutions will serve to embed Clarivate into critical client workflows and enable the expansion of Clarivate services into new markets.
Henry Levy, President, Life Sciences & Healthcare, Clarivate, said: “Clarivate continues to explore, develop and integrate next-generation workflow automation software that streamlines and digitizes manual workflows. The acquisition of Global Q builds on our strategy to deliver solutions that empower our clients to advance treatments that improve patient lives. The combined expertise, data and technologies of Clarivate and Global Q will help to address the client need for connected data to support complex analyses and evidence-based decisions in the life sciences.”
Mitch Hayes, Founder & Chief Executive Officer, Global QMS, Inc., said: “The acquisition of Global Q by Clarivate reinforces our joint missions to help global organizations obtain profound insights and efficiencies in bringing life-saving therapies to their patients worldwide. The combined business will further the vision of putting contextually aware intelligence directly into our customers’ workflows and facilitating their daily tasks in ways never before possible.”
Life sciences professionals responsible for new product development, manufacturing and regulatory compliance are looking to connect the dots across multiple data points to accelerate their treatment and prevention efforts and realize better patient health outcomes. Harmonized and connected data sources can address the industry need for content authoring automation spanning multiple systems and workflows. The acquisition of Global Q enables Clarivate to seamlessly tap into the digital thread market, allowing for proprietary data and insights gleaned from Clarivate solutions to frictionlessly be integrated into customer workflows.
Following the successful acquisition and integration of companies, including Decision Resources Group (DRG), Bioinfogate, Patient Connect, Dialog (part of ProQuest) and IP from MotionHall, the acquisition of Global Q further demonstrates the continuing investment by Clarivate in high-value data, analytics and innovative technology paired with deep subject matter and technical expertise within its Life Sciences and Healthcare segment.
As a trusted partner in shaping the future of healthcare, Clarivate proactively addresses industry demands through intelligence platforms that connect data and use AI and advanced analytics to revolutionize patient engagement, overcome access barriers and fulfill unmet needs. The complementary solutions of Clarivate and Global Q will better position the company in a market that favors innovative tech-enabled providers with end-to-end capabilities and unique market-leading data sets.
Forward-Looking Statements This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words.  Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are difficult to predict and many of which are outside of our control. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also impair our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.  
About Clarivate Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com 
About Global QMS, Inc.Global QMS, Inc., known as Global Q, is a provider of a cloud-based intelligent workflow platform that gives our customers an interconnected workspace that allows them to have a composite view of all their product data (“digital threads”), including internal R&D, post market, regulatory, manufacturing, and others, as well as external feeds and real-world data.
Media Contact: Catherine Daniel, Director, External Communications [email protected]
Investor Relations Contact  Mark Donohue, Head of Investor Relations [email protected]  
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-acquires-global-qms-inc-expanding-life-sciences–healthcare-segment-into-new-markets-302124077.html

Continue Reading

Artificial Intelligence

9fin grows leadership team with VP Content promotion

Published

on

9fin-grows-leadership-team-with-vp-content-promotion

9fin has bolstered its senior leadership team with an internal promotion for a newly created VP Content positionThe promotion demonstrates the strong bench of leadership talent at 9fin and will ensure the company’s content offering continues to be best in classThe company continues to expand with open roles in its US and UK officesNEW YORK, April 23, 2024 /PRNewswire/ — 9fin (https://9fin.com/), a news and analytics platform for debt capital markets, has announced the promotion of Will Caiger-Smith to VP Content, as the business continues to scale rapidly across Europe and the US.

Will was previously 9fin’s US Managing Editor. In his new VP Content role, he joins Jen Speirs, who was promoted to VP Operations last year, in the company’s growing leadership team.
Both VP positions have global mandates and demonstrate 9fin’s continued investment in people and its commitment to rapidly progressing talented leaders within the business.
As VP Content, Will directs all news and analytics across the editorial, credit, legal and ESG teams. The promotion comes as 9fin has expanded from its core leveraged finance coverage into private credit, distressed debt, and structured credit (CLOs) across Europe and the US. These new verticals further the company’s mission to be the #1 provider of data, news and analytics globally across debt capital markets.
Will continues to report directly to 9fin’s CEO and co-founder Steven Hunter.
Will Caiger-Smith commented:
“I joined 9fin because I believed the company and its founders had the vision and technology to build the comprehensive debt intelligence platform the market needs,” said Will. “In my two and a half years at this company, that belief has only intensified. I’m delighted to be driving forward the content side of the business.”
Steven Hunter, CEO and co-founder of 9fin, said:
“I’ve been incredibly impressed by Will’s contributions to scaling 9fin in just a couple of years. He opened and scaled our US office from scratch and has built a world-class team. I am delighted to see him promoted into a new expanded role and join Jen as part of our VP level leadership. I am excited to work with them both to take 9fin to the next level”
About 9fin
9fin is the faster, smarter way to find intelligence on leveraged credit. Our AI-powered data and analytics platform centralises everything that’s needed to analyse a credit or win a mandate in one place, helping subscribers win business, outperform their peers, and save time. 9fin is trusted by the largest asset managers in the world, leading law firms and advisers  in debt capital markets, and nine of the top 10 investment banks.
Photo – https://mma.prnewswire.com/media/2394643/9fin_leadership_team_vp_content.jpg

View original content:https://www.prnewswire.co.uk/news-releases/9fin-grows-leadership-team-with-vp-content-promotion-302124480.html

Continue Reading

Trending